AMH and cancer: Another study found that 44 cancer patients of reproductive age had lower pre-treatment AMH levels than non-cancer patients, with a mean of 1.11 [0.08–4.65] ng/mL versus 3.99 [1.19–8.7] ng/mL (p-value < 0.001) [3].